Ben Enejo is a Cutter Consortium Senior Consultant and a principal at Arthur D. Little. He is an experienced life science management consultant and has worked with various global pharmaceutical and medical device companies on business transformation initiatives. He has managed complex programs, including pharma development, new product and service introduction, market entry strategy and capability development, commercial due diligence, quality and pharmacovigilance transformation.
Ben holds a B.Sc. in physiology and pharmacology from Nottingham Trent University, and MSC in molecular science from Cranfield University, and earned his MBA from the Cranfield School of Management. He can be reached at firstname.lastname@example.org.